Posts
January 11 2012
Ellenoff Grossman & Schole LLP was ranked #4 for issuer representation in IPO transactions (by number of transactions) for 2011.
January 04 2012
Ellenoff Grossman & Schole LLP was ranked #1 for placement agent representation in PIPE transactions (by number of transactions) for 2011.
December 30 2011
AspenBio Pharma, Inc. announced the closing of their registered direct offering in the amount of $1,637,100. EG&S acted as counsel to the Placement Agent.
December 28 2011
Oculus Innovative Sciences, Inc. announced the closing of their registered direct offering in the amount of $2,081,100. EG&S acted as counsel to the Placement Agent.
December 28 2011
Quadrant 4 Systems Corporation announced the closing of their private placement in the amount of $800,000. EG&S acted as counsel to the Investor.
December 27 2011
Catasys, Inc. announced the closing of their registered direct offering in the amount of $974,999. EG&S acted as counsel to the Placement Agent.
December 21 2011
StemCells, Inc. announced the closing of their underwritten public offering in the amount of $10,000,000. EG&S acted as counsel to the Underwriter.
December 13 2011
PhotoMedex, Inc., a NASDAQ listed company, and Radiancy, Inc., a private Delaware company, announced the completion of their merger. Pursuant to the merger, the former stockholders of Radiancy received shares of Photomedex valued on the date of closing at approximately $235 million and collectively own approximately 75% of PhotoMedex, Inc. following the merger. Radiancy became a majority-owned subsidiary of PhotoMedex. EG&S acted as counsel to Radiancy.